MEP urges EMA to postpone adoption of data disclosure policy
This article was originally published in SRA
Executive Summary
Just days before the European Medicines Agency's management board is due to adopt its new policy on the disclosure of clinical trial data, the MEP who steered the landmark Clinical Trials Regulation through the European Parliament has called on the agency to postpone its decision1.